Impel Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results on Friday, March 24, 2023

March 17, 2023

https://www.globenewswire.com/news-release/2023/03/17/2629442/0/en/Impel-Pharmaceuticals-to-Report-Fourth-Quarter-and-Full-Year-2022-Financial-Results-on-Friday-March-24-2023.html

SEATTLE, March 17, 2023 (GLOBE NEWSWIRE) — Impel Pharmaceuticals Inc. (NASDAQ:IMPL), a commercial-stage pharmaceutical company developing transformative therapies for people suffering from diseases with high unmet medical needs, today announced it will host a live webcast on Friday, March 24, 2023, at 8:30 a.m. ET to report its fourth quarter and full year 2022 financial results and provide a business update.

Read more at globenewswire.com

Related news for (IMPL)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.